CKB and Alzheimer disease: Burbaeva and colleagues documented that the concentration of cytosolic CK‐BB in brain samples from individuals who had AD or schizophrenia, and who had undergone autopsy, was considerably lower compared to levels found in analogous control brain samples (Burbaeva, Savushkina, and Dmitriev 1999).